Journal of Medical Case Reports | |
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report | |
Hosam Alardati1  Abdulrahman Qatomah2  Majidah Bukhari2  Mohammad Mawardi2  Edward Cupler3  | |
[1] Department of Histopathology, King Faisal Specialist Hospital and Research Center, Prince Sultan Street, Ar Rawdah, 23433, Jeddah, Saudi Arabia;Department of Internal Medicine, Royal Victoria Hospital, McGill University, 1001 Decarie Blv, H4A 3J1, Montréal, Canada;Department of Neurology, King Faisal Specialist Hospital and Research Center, Prince Sultan Street, Ar Rawdah, 23433, Jeddah, Saudi Arabia; | |
关键词: Direct antiviral therapy; Rhabdomyolysis; Creatine kinase; Sofosbuvir; Case report; | |
DOI : 10.1186/s13256-021-03138-0 | |
来源: Springer | |
【 摘 要 】
IntroductionTreatment of hepatitis C infection has evolved dramatically since 2011. Previous conventional therapy with interferon and ribavirin used to have a low sustained virological response rate of less than 40%. In the new direct-acting antiviral therapy era, a sustained virological response can be achieved in more than 90% of cases.Case presentationWe report a rare case of severe reversible acute rhabdomyolysis in a 31-year-old Saudi male patient with very long-chain acyl-coenzyme A dehydrogenase deficiency and chronic hepatitis C infection. The patient was clinically asymptomatic with no signs of decompensated liver disease.The patient received new direct-acting antiviral agents: sofosbuvir and daclatasvir. Fourteen days after initiation of direct-acting antiviral agents, the patient was found to have asymptomatic rhabdomyolysis. His creatine kinase peaked at 2572 IU/l, and he was treated conservatively; the direct-acting antiviral agents were discontinued and within 7 days, the patient’s creatine kinase levels normalized.ConclusionThis case highlights possible direct-acting antiviral agent-induced rhabdomyolysis in a patient with very-long-chain acyl-CoA dehydrogenase deficiency, presumably through alteration of mitochondrial membrane potential. Further studies are required to assess the possible impact and associations.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202203048815137ZK.pdf | 1010KB | download |